查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1891250

单细胞定序市场：产业趋势及全球预测（至 2035 年）－按系统类型、最终使用者、应用领域和主要地区划分

Single Cell Sequencing Market: Industry Trends and Global Forecasts, Till 2035 - Distribution by Type of System, End-user, Area of Application, and Key Geographies
出版日期: | 出版商: Roots Analysis | 英文 220 Pages | 商品交期: 最快1-2个工作天内

价格

单细胞定序市场概述

预计单细胞定序市场规模将从今年的 13.87 亿美元成长，到 2035 年将以 15% 的复合年增长率 (CAGR) 持续成长。

单细胞定序服务与技术市场概述

市场规模和机会分析基于以下参数进行细分：

市场区隔

  • 服务
  • 技术

系统类型

  • 定序
  • 工作流程设备

最终使用者

  • 学术和研究机构机构
  • 製药公司
  • 其他

应用

  • 诊断
  • 药物发现
  • 精准医疗

主要地区

  • 北美
  • 欧洲
  • 亚太地区
  • 世界其他地区

单细胞定序市场 - 成长与趋势

近年来，基因组学领域的技术进步使製药公司能够采取更个人化和精准的药物和治疗研发方法。特别是新一代定序 (NGS) 技术，使得对来自不同背景的数百万个个人类基因组进行定序成为可能。从这些定序研究中收集的大量基因组数据，为了解个体对各种治疗方案的可能反应提供了重要的见解。该领域的进步使得 NGS 技术更具成本效益，并且广泛应用。过去20年间，单一基因组定序的成本已从约30亿美元（1990年人类基因组计画）降至1,000美元（Illumina定序试剂盒）。然而，基于NGS的分析在提供足够的基因表现资讯方面有其限制。此方法无法量化单一细胞内的核酸含量，因此无法提供单细胞层级的基因表现数据。为了更深入了解单一细胞如何与其微环境相互作用，需要更先进的分子探测技术。在此背景下，高通量单细胞分析作为一种新型分析技术，被认为是研究单一细胞的有效方法，使科学家能够在单细胞层级研究基因表现。

单细胞技术相比传统基因组分析具有许多优势，能够识别复杂和稀有的细胞群，并揭示独特的细胞谱系发育途径。儘管单细胞技术在生物技术和医学研究领域具有广泛的潜在应用，但目前仍处于初步研究阶段。 这主要是由于资料处理和品质控制方面存在一些困难。此外，电脑辅助工具缺乏弹性也被认为是有效分析和解读单细胞定序资料的主要障碍之一。同时，持续的流程执行成本和相关的劳力密集操作流程也进一步阻碍了单细胞定序技术的广泛应用。旨在解决数据处理和品质控制难题的RNA-QC-Chain工具的发布，以及致力于构建首个人类细胞全转录组图谱的人类细胞图谱计划，被认为是单细胞基因组学领域的重要里程碑。鑑于单细胞RNA定序（scRNA-seq）技术能够探索以往难以捉摸的细胞过程，并发现新的生物标记和治疗靶点，预计该技术在预测期内将实现显着的市场增长，并在生物医学研究领域中广泛应用。

单细胞定序服务与技术市场－关键洞察

本报告深入分析了单细胞定序服务与科技市场的现状，并指出了该产业的潜在成长机会。报告的主要发现包括：

  • 目前，全球近100家公司声称提供单细胞定序服务，并采用各种专有技术平台。
单细胞定序市场-IMG1
  • 当前市场格局的特点是，已开发地区存在着许多非行业参与者，而一些行业参与者则是近期才进入这一新兴领域。
  • 技术供应商正在稳步加强其产品组合，以在行业中建立竞争优势。
  • 多年来，与单细胞定序系统相关的智慧财产权以惊人的速度成长，其中大部分专利申请都在北美。
单细胞定序市场-IMG2
  • 鑑于这一新兴领域的潜力，自2016年以来，各机构已授予超过2300项资助，总额约10亿美元。
  • 该领域资本投资、合作协议和产品发布的激增也反映出人们日益增长的兴趣。
  • 由于对单细胞基因组数据的需求不断增长，以及先进定序技术的预期应用，预计未来十年该市场将以每年约17%的速度成长。
单细胞定序市场-IMG3
  • 预计单细胞定序市场的商业机会将广泛分布于全球各个应用领域和终端用户。

单细胞定序市场 - 主要细分市场

定序系统预计将占目前单细胞定序市场占有率的大部分。

依仪器类型划分，市场可分为各种仪器，包括工作流程仪器及定序仪器。今年，定序仪器占了大部分市场占有率（约 51%）。然而，预计在预测期内，工作流程仪器的复合年增长率将达到 34%。

目前，学术研究机构占单细胞定序市场最大的占有率。

依最终用户划分，单细胞定序市场可分为学术研究机构、製药公司和其他最终用户。目前，学术研究机构占了大部分市场占有率（约 60%），其次是製药公司（30%）。预计未来几年这一趋势将保持稳定。

目前，学术研究机构占单细胞定序市场最大的占有率。

依最终用户划分，单细胞定序市场可分为学术研究机构、製药公司和其他最终用户。目前，学术研究机构占了大部分市场占有率（约 60%），其次是製药公司（30%）。预计未来几年这一趋势将保持稳定。

预计未来药物研发将占单细胞定序市场最大的占有率。

依应用领域划分，单细胞定序市场可分为药物研发、诊断、精准医疗及其他领域。预计药物研发将占约 50% 的市场占有率，其次是诊断（20%）和精准医疗（17%）。

预计北美将引领单细胞定序市场。

依地区划分，单细胞定序市场可分为北美、欧洲、亚太地区及世界其他地区。预计北美将占约 50% 的市场占有率，其次是欧洲（26%）和亚太地区（24%）。

单细胞定序市场代表性公司

  • Active Motif
  • Admera Health
  • 安诺路德基因组
  • 华大基因
  • CD Genomics
  • MedGenome
  • Quick Biology
  • SingulOmics
  • 10x Genomics
  • Cell Microsystems
  • Fluidigm
  • Illumina
  • Mission Bio
  • Oxford Nanopore Technologies

单细胞服务与技术市场 - 范围

  • 市场规模与机会分析：本报告对单细胞定序市场进行了详细分析，重点关注以下关键市场细分：[A] 市场细分，[B] 系统类型，[C] 最终用户，[D] 应用领域，以及 [E]重点区域。
  • 市场概况：基于相关参数（例如[A] 目标核酸、[B] 应用类型、[C] 应用类型、[D] 成立年份、[E] 公司规模和[F] 地理位置）对单细胞定序工作流程设备的整体竞争格局进行深入评估。
  • 公司竞争分析：对单细胞技术进行全面的竞争分析，检视供应商实力和其他关键技术相关规格，例如最大定序产量、每次运行最大读取数、最大读取长度、品质评分、应用领域和定序仪成本。
  • 公司简介：基于多个参数（例如[A] 成立年份、[B] 总部所在地、[C] 专有技术平台、[D] 近期发展和[E] 未来展望）对提供单细胞测序服务和单细胞技术的公司进行详细介绍。
  • 专利分析：基于以下参数，对单细胞定序技术相关的各类专利申请和授权进行深入分析：[A] 专利类型，[B] 公开年份，[C] 地理位置，[D] 合作专利分类 (CPC) 代码，[E] 新兴和热点领域，以及 [F] 申请人类型。
  • 资助分析：针对授予从事单细胞测序相关项目的研究机构的资助，分析以下参数：[A] 资助年份，[B] 资助金额，[C] 重点领域，[D] 活动代码，[E] 支持期限，[F] 资助机制，[G] 资助机构中心，[H] 受资助方类型，[I] 资助者主要受资助机构中心，[H] 受资助方类型，[I] 主要受资助方负责项目。
  • 近期趋势：对单细胞定序领域近期发展与趋势的深入分析。重点在于[A]产业内建立的合作关係，[B]资金和投资，以及[C]近期单细胞定序相关产品的发布。

目录

第一章：前言

第二章：摘要整理

第三章：导论

  • 章节概述
  • 单细胞定序概述
  • 单细胞定序的应用
  • 单细胞定序面临的挑战
  • 未来展望

第四章：市场概况：单细胞定序服务提供者

  • 章节概述
  • 单细胞定序服务提供者：产业参与者的市场概况
  • 单细胞定序服务提供者：非产业参与者的市场概况参与者

第五章 市场概况：单细胞定序技术供应商

  • 章节概述
  • 单细胞定序系统与技术：工作流程仪器市场概况
  • 单细胞定序系统与技术：开发者视角
  • 单细胞定序系统与技术：定序仪器市场概况
  • 单细胞定序系统与技术：开发者视角

第六章：单细胞定序技术：竞争分析

第七章：公司简介：单细胞定序服务提供者

  • 章节概述
  • Active Motif
  • Admera Health
  • Annoroad基因体学
  • 华大基因
  • CD Genomics
  • MedGenome
  • Quick Biology
  • SingulOmics

第八章：公司简介：单细胞定序技术提供者

  • 10x Genomics
  • Cell Microsystems
  • Fluidigm
  • Illumina
  • Mission Bio
  • Oxford Nanopore Technologies

第九章：专利分析

  • 章节概述
  • 范围与研究方法
  • 单细胞定序：专利分析
  • 单细胞定序：基准分析
  • 单细胞定序：专利估值分析

第十章 学术资助分析

  • 章节概述
  • 研究范围与方法
  • 单细胞定序：学术资助分析

第十一章：近期趋势：单细胞定序市场

  • 章节概述
  • 单细胞定序：近期合作
  • 单细胞定序：近期融资与投资
  • 单细胞定序：近期产品发布

第十二章 市场规模评估与机会分析

  • 章节概述
  • 关键假设与预测研究方法论
  • 单细胞定序服务和技术的整体市场机会
  • 到 2030 年，主要细分市场中单细胞定序服务和技术的市场机会
  • 2020 年和 2030 年，按系统类型划分的单细胞定序服务和技术的市场机会
  • 2020 年和 2030 年，按最终用户划分的单细胞测序服务和技术的市场机会
  • 2020 年和 2030 年，按应用领域划分的单细胞定序服务和技术的市场机会
  • 2020 年和 2030 年，按地域划分的单细胞定序服务和技术的市场机会

第十三章：结论

第十四章：摘要整理见解

第十五章：附录一：表格资料

Product Code: RA100224

Single Cell Sequencing Market: Overview

As per Roots Analysis, the single cell sequencing market is estimated to grow from USD 1,387 million in the current year and is anticipated to grow at a CAGR of 15% during the forecast period, till 2035.

Single Cell Sequencing Services and Technologies Market: Overview

The market sizing and opportunity analysis has been segmented across the following parameters:

Market Segment

  • Services
  • Technologies

Type of System

  • Sequencing
  • Workflow Instruments

End-user

  • Academics and Research Institutes
  • Pharmaceutical Companies
  • Other End-users

Area of Application

  • Diagnostics
  • Drug Discovery
  • Precision Medicine

Key Geographies

  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World

Single Cell Sequencing market: Growth and Trends

Over the years, advancements in technology within genomics have allowed pharmaceutical companies to pursue a more individualized and focused method for developing drugs and therapies. In particular, next-generation sequencing (NGS) technologies have made it possible to sequence millions of human genomes from various backgrounds. The significant amount of blockchain in genomic data management from the previously mentioned sequencing studies have produced important insights into individuals' probable reactions to various treatment protocols. Advancements in this area have made NGS technologies more cost-effective and widely available. The price of sequencing one genome has decreased from approximately USD 3 billion (Human Genome Project 1990) to USD 1,000 (Illumina sequencing kits) in the past twenty years. Nonetheless, NGS-based analyses are restricted to providing adequate information on gene expression. This method cannot quantify nucleic acid content within individual cells, thus failing to provide gene expression data at single cell resolution. Enhanced molecular probing solutions are needed to gain a deeper insight into how individual cells interact with their microenvironment. In this setting, high-throughput single cell analysis, a novel analytical method, is regarded as an effective approach for examining individual cells, allowing scientists to investigate gene expression at the resolution of single cells.

Single cell technologies provide numerous benefits compared to conventional genomic analyses, allowing for the identification of intricate and infrequent cell populations, while clarifying developmental pathways of unique cell lineages. Although single cell technologies have the potential for various applications in biotechnology and medical research, they remain confined to preliminary research endeavors. This is mainly due to specific difficulties linked to data processing and quality management. Additionally, the absence of flexibility in silico tools is viewed as one of the key obstacles to effective analysis and interpretation of single cell sequencing data. Moreover, the steady expenses of process execution and related labor-intensive protocols present additional obstacles to embracing single cell sequencing technology. The launch of the RNA-QC-Chain tool (aimed at tackling issues related to data processing and quality control) and the Human Cell Atlas initiative (which focuses on creating the first entire transcriptome map of human cells) are viewed as significant milestones in single cell genomics.onsidering the capability of single cell RNA sequencing (scRNA-seq) technologies to explore previously unclear cellular processes and discover new biomarkers / therapeutic targets, they are expected to experience considerable market growth and acceptance in biomedical research throughout the forecast period.

Single Cell Sequencing Services and Technologies Market: Key Insights

The report delves into the current state of the single cell sequencing services and technologies market and identifies potential growth opportunities within industry. Some key findings from the report include:

  • Presently, close to 100 players claim to offer single cell sequencing services using a variety of unique technology platforms across the globe.
Single Cell Sequencing Market - IMG1
  • The current market landscape is characterized by the presence of several non-industry players based in developed regions; quite recently, some industry players have entered this upcoming segment of the industry.
  • Technology providers are steadily enhancing their respective product portfolios in order to achieve a competitive edge in the industry.
  • Over the years, the intellectual capital related to single cell sequencing systems has grown at a commendable pace; majority of the patents have been filed in North America.
Single Cell Sequencing Market - IMG2
  • Several organizations, having realized the untapped potential within this emerging segment, have awarded grants worth ~USD 1 billion, across 2,300+ instances in the period since 2016.
  • The growing interest is also reflected by the surge of activity witnessed in this field, in form of capital investments, partnership agreements and product launches.
  • Given the rising demand for single cell genomic data, and anticipated introduction of advanced sequencing technologies, the market is poised to grow at an annualized rate of ~17% over the next decade.
Single Cell Sequencing Market - IMG3
  • The projected opportunity within the single cell sequencing market is expected to be well distributed within different areas of application and end users, across the globe.

Single Cell Sequencing Market: Key Segments

Sequencing Systems are Likely to Capture Majority of the Current Single-cell Sequencing Market Share

In terms of type of instrument, the single-cell sequencing market is segmented across various instruments such as workflow and sequencing instruments. In the current year, majority of the market share is captured by sequencing instruments (around 51%). However, the workflow segment is likely to grow at a higher CAGR of 34% during the forecast period.

Currently, Academic and Research Institutions Capture the Highest Singe Cell Sequencing Market Share

In terms of end-users, the single-cell sequencing market is segmented across academic and research institutions, pharmaceutical companies and other end-users. Most of the current market share is captured by academic and research institutions (around 60%), followed by pharmaceutical companies (30%). The trend is likely to similar in the coming years.

At present, Academic and Research Institutions Capture the Highest Single Cell Sequencing Market Share

In terms of end-users, the single-cell sequencing market is segmented across academic and research institutions, pharmaceutical companies and other end-users. Most of the current market share is captured by academic and research institutions (around 60%), followed by pharmaceutical companies (30%). The trend is likely to similar in the coming years.

Drug Discovery Segment is Likely to Capture the Highest Singe Cell Sequencing Market Share in the Future

In terms of area of application, the single-cell sequencing market is segmented across drug discovery, diagnostics, precision medicine and others. Around 50% of the market share is likely to be captured by drug discovery segment, followed by diagnostics (20%) and precision medicine (17%).

North America is Likely to Propel the Single-cell Sequencing Market

In terms of geographical regions, the single-cell sequencing market is segmented across North America, Europe, Asia-Pacific and Rest of the World. Around 50% of the market share is likely to be captured by North America, followed by Europe (26%) and Asia-Pacific (24%).

Example Players in Single cell Sequencing Market

  • Active Motif
  • Admera Health
  • Annoroad Genomics
  • BGI Genomics
  • CD Genomics
  • MedGenome
  • Quick Biology
  • SingulOmics
  • 10x Genomics
  • Cell Microsystems
  • Fluidigm
  • Illumina
  • Mission Bio
  • Oxford Nanopore Technologies

Single Cell Services and Technologies Market: Research Coverage

  • Market Sizing and Opportunity Analysis: The report features an in-depth analysis of the single cell sequencing market, focusing on key market segments, including [A] market segments, [B] type of system, [C] end-user, [D] area of application, and [E] key geographical regions.
  • Market Landscape: A detailed assessment of overall competitive landscape of single cell sequencing workflow instruments based on several relevant parameters, such as [A] target nucleic acid, [B] type of application, [C] type of application, [D] year of establishment, [E] company size and [F] geographical location.
  • Company Competitiveness Analysis: A comprehensive competitive analysis of single cell technologies examining factors, such as supplier power and other important technology related specifications, such as maximum sequencing output, maximum reads per run, maximum read length, quality score, applications and cost of sequencer.
  • Company Profiles: In-depth profiles of single cell companies that are engaged in offering single cell sequencing services and single cell technologies, based on several parameters such as [A] year of establishment, [B] location of headquarters, [C] proprietary technology platforms, [D] recent developments and [E] an informed future outlook.
  • Patent Analysis: An insightful analysis of the various patents that have been filed / granted for single cell sequencing technologies, based on parameters, such as [A] patent type, [B] publication year, [C] geographical location, [D] Cooperative Patent Classification (CPC) symbols, [E] emerging focus areas, and [F] type of applicant.
  • Grants Analysis: A detailed analysis of the grants that have been awarded to research institutes engaged in projects related to single cell sequencing, based on multiple parameters, such as [A] year of grant award, [B] grant amount, [C] focus area, [D] activity code, [E] support period, [F] funding mechanism, [G] funding institute center, [H] type of recipient organization, [I] popular recipient organizations and [J] prominent program officers.
  • Recent Developments: An insightful analysis of the recent developments / trends in the related to single cell sequencing, offering insights on [A] partnerships and collaborations established within the industry, [B] funding and investments, and [C] recent product launches related to single cell sequencing.

Key Questions Answered in this Report

  • How many companies are currently engaged in this market?
  • Which are the leading companies in this market?
  • What is the current global capacity of developers?
  • What factors are likely to influence the evolution of this market?
  • What is the current and future market size?
  • What is the CAGR of this market?
  • How is the current and future market opportunity likely to be distributed across key market segments?

Reasons to Buy this Report

  • The report provides a comprehensive market analysis, offering detailed revenue projections of the overall market and its specific sub-segments. This information is valuable to both established market leaders and emerging entrants.
  • Stakeholders can leverage the report to gain a deeper understanding of the competitive dynamics within the market. By analyzing the competitive landscape, businesses can make informed decisions to optimize their market positioning and develop effective go-to-market strategies.
  • The report offers stakeholders a comprehensive overview of the market, including key drivers, barriers, opportunities, and challenges. This information empowers stakeholders to stay abreast of market trends and make data-driven decisions to capitalize on growth prospects.

Additional Benefits

  • Complimentary PPT Insights Packs
  • Complimentary Excel Data Packs for all Analytical Modules in the Report
  • 15% Free Content Customization
  • Detailed Report Walkthrough Session with Research Team
  • Free Updated report if the report is 6-12 months old or older

TABLE OF CONTENTS

1. PREFACE

  • 1.1. Scope of the Report
  • 1.2. Research and Methodology
  • 1.3. Key Questions Answered
  • 1.4. Chapter Outlines

2. EXECUTIVE SUMMARY

3. INTRODUCTION

  • 3.1. Chapter Overview
  • 3.2. Overview of Single cell Sequencing
    • 3.2.1. Comparison of Bulk RNA and Single cell RNA Sequencing
  • 3.3. Applications of Single cell Sequencing
    • 3.3.1. In Cancer Research
    • 3.3.2. In Clinical Diagnostics
    • 3.3.3. In Drug Discovery
    • 3.3.4. In Embryology
    • 3.3.5. In Immunology
    • 3.3.6. In Microbiology
    • 3.3.7. In Neurology
    • 3.3.8. In Organ Development
  • 3.4. Challenges Associated with Single cell Sequencing
    • 3.4.1. Data Pre-processing
    • 3.4.2. Low Capturing Efficiency
    • 3.4.3. Rigid and Undefined Statistical Frameworks
    • 3.4.4. Lack of Appropriate Quality Control Systems
  • 3.5. Future Perspectives

4. MARKET LANDSCAPE: SINGLE CELL SEQUENCING SERVICE PROVIDERS

  • 4.1. Chapter Overview
  • 4.2. Single cell Sequencing Service Providers: Market Landscape of Industry Players
    • 4.2.1. Analysis by Year of Establishment
    • 4.2.2. Analysis by Company Size
    • 4.2.3. Analysis by Location of Headquarters
    • 4.2.4. Analysis by Sequencing Method Used
    • 4.2.5. Analysis by Type of Service Offered
    • 4.2.6. Analysis by Type of Library Preparation System Used
    • 4.2.7. Analysis by Type of Sequencing System Used
  • 4.3. Single cell Sequencing Service Providers: Market Landscape of Non-Industry Players
    • 4.3.1. Analysis by Location of Organization
    • 4.3.2. Analysis by Sequencing Method Used
    • 4.3.3. Analysis by Type of Service Offered
    • 4.3.4. Analysis by Type of Library Preparation System Used
    • 4.3.5. Analysis by Type of Sequencing System Used

5. MARKET LANDSCAPE: SINGLE CELL SEQUENCING TECHNOLOGY PROVIDERS

  • 5.1. Chapter Overview
  • 5.2. Single cell Sequencing Systems and Technologies: Market Landscape of Workflow Instruments
    • 5.2.1. Analysis by Target Nucleic Acid
    • 5.2.2. Analysis by Type of Application
    • 5.2.3. Analysis by Throughput
  • 5.3. Single cell Sequencing Systems and Technologies: Developer Landscape
    • 5.3.4. Analysis by Year of Establishment
    • 5.3.5. Analysis by Company Size
    • 5.3.6. Analysis by Location of Headquarters
  • 5.4. Single cell Sequencing Systems and Technologies: Market Landscape of Sequencing Instruments
    • 5.4.1. Analysis by Type of Application
    • 5.4.2. Analysis by Maximum Output
    • 5.4.3. Analysis by Maximum Read Length
    • 5.4.4. Analysis by System Efficiency
    • 5.4.5. Analysis by Sequencing Chemistry
  • 5.5. Single cell Sequencing Systems and Technologies: Developer Landscape
    • 5.5.6. Analysis by Year of Establishment
    • 5.5.7. Analysis by Company Size
    • 5.5.8. Analysis by Location of Headquarters

6. SINGLE CELL SEQUENCING TECHNOLOGIES: COMPETITIVENESS ANALYSIS

  • 6.1. Chapter Overview
  • 6.2. Key Parameters and Methodology
  • 6.3. Competitiveness Analysis: Single cell Workflow Instruments
  • 6.4. Competitiveness Analysis: Single cell Sequencing Instruments

7. COMPANY PROFILES: SINGLE CELL SEQUENCING SERVICE PROVIDERS

  • 7.1. Chapter Overview
  • 7.2. Active Motif
    • 7.2.1. Company Overview
    • 7.2.2. Recent Developments and Future Outlook
  • 7.3. Admera Health
    • 7.3.1. Company Overview
    • 7.3.2. Recent Developments and Future Outlook
  • 7.4. Annoroad Genomics
    • 7.4.1. Company Overview
    • 7.4.2. Recent Developments and Future Outlook
  • 7.5. BGI Genomics
    • 7.5.1. Company Overview
    • 7.5.2. Recent Developments and Future Outlook
  • 7.6. CD Genomics
    • 7.6.1. Company Overview
    • 7.6.2. Recent Developments and Future Outlook
  • 7.7. MedGenome
    • 7.7.1. Company Overview
    • 7.7.2. Recent Developments and Future Outlook
  • 7.8. Quick Biology
    • 7.8.1. Company Overview
    • 7.8.2. Recent Developments and Future Outlook
  • 7.9. SingulOmics
    • 7.9.1. Company Overview
    • 7.9.2. Recent Developments and Future Outlook

8. COMPANY PROFILES: SINGLE CELL SEQUENCING TECHNOLOGY PROVIDERS

  • 8.1. 10x Genomics
    • 8.1.1. Company Overview
    • 8.1.2. Financial Information
    • 8.1.3. Product Portfolio
      • 8.1.3.1. 10x Chromium
    • 8.1.4. Recent Developments and Future Outlook
  • 8.2. Cell Microsystems
    • 8.2.1. Company Overview
    • 8.2.2. Product Portfolio
      • 8.2.2.1. Cellraft AIR
  • 8.3. Fluidigm
    • 8.3.1. Company Overview
    • 8.3.2. Financial information
    • 8.3.3. Product Portfolio
      • 8.3.3.1. Fluidigm C1
    • 8.3.4. Recent Developments and Future Outlook
  • 8.4. Illumina
    • 8.4.2. Financial Information
    • 8.4.3. Product Portfolio
      • 8.4.3.1. MiSeq Series
      • 8.4.3.2. Nextseq Series
      • 8.4.3.3. NovaSeq 6000 System
    • 8.4.4. Recent Developments and Future Outlook
  • 8.5. Mission Bio
    • 8.5.1. Company Overview
    • 8.5.2. Product Portfolio
      • 8.5.2.1. Tapestri
    • 8.5.3. Recent Developments and Future Outlook
  • 8.6. Oxford Nanopore Technologies
    • 8.6.1. Company Overview
    • 8.6.2. Financial Information
    • 8.6.3. Product Portfolio
      • 8.6.3.1. MinIon Systems
      • 8.6.3.2. PromethIon Systems
    • 8.6.4. Recent Developments and Future Outlook

9. PATENT ANALYSIS

  • 9.1. Chapter Overview
  • 9.2. Scope and Methodology
  • 9.3. Single cell Sequencing: Patent Analysis
    • 9.3.1. Analysis by Publication Year
    • 9.3.2. Analysis by Geographical Location
    • 9.3.3. Analysis by CPC Symbols
    • 9.3.4. Word Cloud: Emerging Focus Areas
    • 9.3.5. Analysis by Type of Applicant
    • 9.3.6. Leading Players: Analysis by Number of Patents
  • 9.4. Single cell Sequencing: Benchmarking Analysis
    • 9.4.1. Analysis by Patent Characteristics
    • 9.4.2. Analysis by Geography
  • 9.5. Single cell Sequencing: Patent Valuation Analysis

10. ACADEMIC GRANT ANALYSIS

  • 10.1. Chapter Overview
  • 10.2. Scope and Methodology
  • 10.3. Single cell Sequencing: Analysis of Academic Grants
    • 10.3.1. Analysis by Year of Grant Award
    • 10.3.2. Analysis by Grant Amount
    • 10.3.3. Analysis by Focus Area
    • 10.3.4. Analysis by Activity Code
    • 10.3.5. Analysis by Support Period
    • 10.3.6. Analysis by Funding Mechanism
    • 10.3.7. Analysis by Funding Institute Center
    • 10.3.8. Analysis by Type of Recipient Organization
    • 10.3.9. Popular Recipient Organizations: Analysis by Number of Grants
    • 10.3.10. Prominent Program Officers: Analysis by Number of Grants

11. RECENT DEVELOPMENTS: SINGLE CELL SEQUENCING MARKET

  • 11.1. Chapter Overview
  • 11.2. Single cell Sequencing: Recent Partnerships
    • 11.2.1. Partnership Models
    • 11.2.2. Analysis by Year of Partnership
    • 11.2.3. Analysis by Type of Agreement
    • 11.2.4. Analysis by Focus Area of Partnership
    • 11.2.5. Regional Analysis by Number of Partnerships
  • 11.3. Single cell Sequencing: Recent Funding and Investments
    • 11.3.1. Analysis by Year of Funding
    • 11.3.3. Analysis by Type of Funding
    • 11.3.2. Analysis by Amount Invested
    • 11.3.4. Most Active Players: Analysis by Amount Invested
    • 11.3.5. Most Active Investors: Analysis by Number of Funding Instances
  • 11.4. Single cell Sequencing: Recent Product Launches
    • 11.4.1. Analysis by Year of Product Launch
    • 11.4.2. Analysis by Type of Product
    • 11.4.3. Analysis by Focus Area
    • 11.4.4. Most Active Players: Analysis by Number of Launches

12. MARKET SIZING AND OPPORTUNITY ANALYSIS

  • 12.1. Chapter Overview
  • 12.2. Key Assumptions and Forecast Methodology
  • 12.3. Overall Single cell Sequencing Services and Technologies Market Opportunity,
  • 12.4. Single cell Sequencing Services and Technologies Market Opportunity Across Key Market Segments, Till 2030
  • 12.5. Single cell Sequencing Services and Technologies Market Opportunity:
  • 12.6. Single cell Sequencing Services and Technologies Market Opportunity: Distribution by End-User 2020 and 2030
  • 12.7. Single cell Sequencing Services and Technologies Market Opportunity: Distribution by Area of Application, 2020 and 2030
  • 12.8. Single cell Sequencing Services and Technologies Market Opportunity: Geographical Distribution, 2020 and 2030
    • 12.8.1. Single cell Sequencing Services and Technologies Market Opportunity in North America, Till 2030
      • 12.8.1.1. Single cell Sequencing Services and Technologies Market Opportunity in North America Across Key Market Segments, Till 2030
        • 12.8.1.1.1. Single cell Sequencing services and Technologies Market Opportunity in North America: Share of Service Providers, Till 2030
        • 12.8.1.1.2. Single cell Sequencing services and Technologies Market Opportunity in North America: Share of Technology Providers, Till 2030
      • 12.8.1.2. Single cell Sequencing Services and Technologies Market Opportunity in North America: Distribution by End-Users, Till 2030
        • 12.8.1.2.1. Single cell Sequencing services and Technologies Market Opportunity in North America: Share of Academic and Research Institutions, Till 2030
        • 12.8.1.2.2. Single cell Sequencing services and Technologies Market Opportunity in North America: Share of Pharmaceutical Companies, Till 2030
        • 12.8.1.2.3. Single cell Sequencing services and Technologies Market Opportunity in North America: Share of Other End-Users, Till 2030
      • 12.8.1.3. Single cell Sequencing Services and Technologies Market Opportunity in North America: Distribution by Area of Application, Till 2030
        • 12.8.1.3.1. Single cell Sequencing services and Technologies Market Opportunity in North America: Share of Diagnostics, Till 2030
        • 12.8.1.3.2. Single cell Sequencing services and Technologies Market Opportunity in North America: Share of Drug Discovery, Till 2030
        • 12.8.1.3.3. Single cell Sequencing services and Technologies Market Opportunity in North America: Share of Precision Medicine, Till 2030
        • 12.8.1.3.4. Single cell Sequencing services and Technologies Market Opportunity in North America: Share of Other Applications, Till 2030
    • 12.8.2. Single cell Sequencing Services and Technologies Market Opportunity in Europe, Till 2030
      • 12.8.2.1. Single cell Sequencing Services and Technologies Market Opportunity in Europe Across Key Market Segments, Till 2030
        • 12.8.2.1.1. Single cell Sequencing services and Technologies Market Opportunity in Europe: Share of Service Providers, Till 2030
        • 12.8.2.1.2. Single cell Sequencing services and Technologies Market Opportunity in Europe: Share of Technology Providers, Till 2030
      • 12.8.2.2. Single cell Sequencing Services and Technologies Market Opportunity in Europe: Distribution by End-Users, Till 2030
        • 12.8.2.2.1. Single cell Sequencing services and Technologies Market Opportunity in Europe: Share of Academic and Research Institutions, Till 2030
        • 12.8.2.2.2. Single cell Sequencing services and Technologies Market Opportunity in Europe: Share of Pharmaceutical Companies, Till 2030
        • 12.8.2.2.3. Single cell Sequencing services and Technologies Market Opportunity in Europe: Share of Other End-Users, Till 2030
      • 12.8.2.3. Single cell Sequencing Services and Technologies Market Opportunity in Europe: Distribution by Area of Application, Till 2030
        • 12.8.2.3.1. Single cell Sequencing services and Technologies Market Opportunity in Europe: Share of Diagnostics, Till 2030
        • 12.8.2.3.2. Single cell Sequencing services and Technologies Market Opportunity in Europe: Share of Drug Discovery, Till 2030
        • 12.8.2.3.3. Single cell Sequencing services and Technologies Market Opportunity in Europe: Share of Precision Medicine, Till 2030
        • 12.8.2.3.4. Single cell Sequencing services and Technologies Market Opportunity in Europe: Share of Other Applications, Till 2030
    • 12.8.3. Single cell Sequencing Services and Technologies Market Opportunity in Asia-Pacific, Till 2030
      • 12.8.3.1. Single cell Sequencing Services and Technologies Market Opportunity in Asia-Pacific Across Key Market Segments, Till 2030
        • 12.8.3.1.1. Single cell Sequencing services and Technologies Market Opportunity in Asia-Pacific: Share of Service Providers, Till 2030
        • 12.8.3.1.2. Single cell Sequencing services and Technologies Market Opportunity in Asia-Pacific: Share of Technology Providers, Till 2030
      • 12.8.3.2. Single cell Sequencing Services and Technologies Market Opportunity in Asia-Pacific: Distribution by End-Users, Till 2030
        • 12.8.3.2.1. Single cell Sequencing services and Technologies Market Opportunity in Asia-Pacific: Share of Academic and Research Institutions, Till 2030
        • 12.8.3.2.2. Single cell Sequencing services and Technologies Market Opportunity in Asia-Pacific: Share of Pharmaceutical Companies, Till 2030
        • 12.8.3.2.3. Single cell Sequencing services and Technologies Market Opportunity in Asia-Pacific: Share of Other End-Users, Till 2030
      • 12.8.3.3. Single cell Sequencing Services and Technologies Market Opportunity in Asia-Pacific: Distribution by Area of Application, Till 2030
        • 12.8.3.3.1. Single cell Sequencing services and Technologies Market Opportunity in Asia-Pacific: Share of Diagnostics, Till 2030
        • 12.8.3.3.2. Single cell Sequencing services and Technologies Market Opportunity in Asia-Pacific: Share of Drug Discovery, Till 2030
        • 12.8.3.3.3. Single cell Sequencing services and Technologies Market Opportunity in Asia-Pacific: Share of Precision Medicine, Till 2030
        • 12.8.3.3.4. Single cell Sequencing services and Technologies Market Opportunity in Asia-Pacific: Share of Other Applications, Till 2030
    • 12.8.4. Single cell Sequencing Services and Technologies Market Opportunity in Rest of the World, Till 2030
      • 12.8.4.1. Single cell Sequencing Services and Technologies Market Opportunity in Rest of the World Across Key Market Segments, Till 2030
        • 12.8.4.1.1. Single cell Sequencing services and Technologies Market Opportunity in Rest of the World: Share of Service Providers, Till 2030
        • 12.8.4.1.2. Single cell Sequencing services and Technologies Market Opportunity in Rest of the World: Share of Technology Providers, Till 2030
      • 12.8.4.2. Single cell Sequencing Services and Technologies Market Opportunity in Rest of the World: Distribution by End-Users, Till 2030
        • 12.8.4.2.1. Single cell Sequencing services and Technologies Market Opportunity in Rest of the World: Share of Academic and Research Institutions, Till 2030
        • 12.8.4.2.2. Single cell Sequencing services and Technologies Market Opportunity in Rest of the World: Share of Pharmaceutical Companies, Till 2030
        • 12.8.4.2.3. Single cell Sequencing services and Technologies Market Opportunity in Rest of the World: Share of Other End-Users, Till 2030
      • 12.8.4.3. Single cell Sequencing Services and Technologies Market Opportunity in Rest of the World: Distribution by Area of Application, Till 2030
        • 12.8.4.3.1. Single cell Sequencing services and Technologies Market Opportunity in Rest of the World: Share of Diagnostics, Till 2030
        • 12.8.4.3.2. Single cell Sequencing services and Technologies Market Opportunity in Rest of the World: Share of Drug Discovery, Till 2030
        • 12.8.4.3.3. Single cell Sequencing services and Technologies Market Opportunity in Rest of the World: Share of Precision Medicine, Till 2030
        • 12.8.4.3.4. Single cell Sequencing services and Technologies Market Opportunity in Rest of the World: Share of Other Applications, Till 2030

13. CONCLUSION

  • 13.1. Chapter Overview
  • 13.2. Key Takeaways

14. EXECUTIVE INSIGHTS

15. APPENDIX I: TABULATED DATA

List of Tables

  • Table 3.1 Comparison of Bulk RNA Sequencing and scRNA Sequencing
  • Table 4.1 Single cell Sequencing Service Providers: List of Industry Players
  • Table 4.2 Single cell Sequencing Service Providers (Industry Players): Information on Sequencing Method, Turn Around Time and Sample Used
  • Table 4.3 Single cell Sequencing Service Providers (Industry Players): Information on Type of Service Offered, Library Preparation System Used and Sequencing System Used
  • Table 4.4 Single cell Sequencing Providers: List of Non-Industry Players
  • Table 4.5 Single cell Sequencing Service Providers (Non-Industry Players): Information on Sequencing Method Used, Turn Around Time and Price of Services
  • Table 4.6 Single cell Sequencing Service Providers (Non-Industry Players): Information on Type of Service Offered, Library Preparation System Used and Sequencing System Used
  • Table 4.7 Additional List of Companies
  • Table 5.1 Single cell Sequencing Workflow Instruments: Information on Name of Developer, Target Nucleic Acid and System Throughput
  • Table 5.2 Single cell Sequencing Workflow Instruments: Information on Type of Application and Analytical Software Used
  • Table 5.3 List of Single cell Sequencing Workflow Instrument Providers
  • Table 5.4 Single cell Sequencing Instruments: Information on Type of Application, Run Time, Maximum Output and Output Range
  • Table 5.5 Single cell Sequencing Instruments: Information on Maximum Reads per Run, Reads per Run, Maximum Read Length, Maximum Quality Score, Sequencing Chemistry and Cost of Instrument
  • Table 5.6 List of Single cell Sequencing Instrument Providers
  • Table 7.1 Single cell Sequencing Service Providers: List of Profiled Companies
  • Table 7.2 Active Motif: Company Snapshot
  • Table 7.3 Admera Health: Company Snapshot
  • Table 7.4 Admera Health: Recent Developments and Future Outlook
  • Table 7.5 Annoroad Genomics: Company Snapshot
  • Table 7.6 Annoroad Genomics: Recent Developments and Future Outlook
  • Table 7.7 BGI Genomics: Company Snapshot
  • Table 7.8 BGI Genomics: Recent Developments and Future Outlook
  • Table 7.9 CD Genomics: Company Snapshot
  • Table 7.10 CD Genomics: Recent Developments and Future Outlook
  • Table 7.11 MedGenome: Company Snapshot
  • Table 7.12 MedGenome: Recent Developments and Future Outlook
  • Table 7.13 Quick Biology: Company Snapshot
  • Table 7.14 Quick Biology: Recent Developments and Future Outlook
  • Table 7.15 SingulOmics: Company Snapshot
  • Table 8.1 10x Genomics: Company Snapshot
  • Table 8.2 10x Genomics: Recent Developments and Future Outlook
  • Table 8.3 Cell Microsystems: Company Snapshot
  • Table 8.4 Fluidigm: Company Snapshot
  • Table 8.5 Fluidigm: Recent Developments and Future Outlook
  • Table 8.6 Illumina: Company Snapshot
  • Table 8.7 Illumina: Recent Developments and Future Outlook
  • Table 8.8 Mission Bio: Company Snapshot
  • Table 8.9 Mission Bio: Recent Developments and Future Outlook
  • Table 8.10 Oxford Nanopore Technologies: Company Snapshot
  • Table 8.11 Oxford Nanopore Technologies: Recent Developments and Future Outlook
  • Table 9.1 Patent Analysis: CPC Symbols
  • Table 9.2 Patent Analysis: Most Popular CPC Symbols
  • Table 9.3 Patent Analysis: List of Top 10 CPC Symbols
  • Table 9.4 Patent Analysis: Categorization based on Weighted Valuation Scores
  • Table 9.5 Patent Analysis: List of Relatively Higher Value Patents
  • Table 15.1 Single cell Sequencing Service Providers (Industry Players): Distribution by Year of Establishment
  • Table 15.2 Single cell Sequencing Service Providers (Industry Players): Distribution by Company Size
  • Table 15.3 Single cell Sequencing Service Providers (Industry Players): Distribution by Location of Headquarters
  • Table 15.4 Single cell Sequencing Service Providers (Industry Players): Distribution by Sequencing Method Used
  • Table 15.5 Single cell Sequencing Service Providers (Industry Players): Distribution by Type of Service Offered
  • Table 15.6 Single cell Sequencing Service Providers (Industry Players): Distribution by Type of Library Preparation System Used
  • Table 15.7 Single cell Sequencing Service Providers (Industry Players): Distribution by Type of Sequencing System Used
  • Table 15.8 Single cell Sequencing Service Providers (Non-Industry Players): Distribution by Location of Organization
  • Table 15.9 Single cell Sequencing Service Providers (Non-Industry Players): Distribution by Sequencing Method Used
  • Table 15.10 Single cell Sequencing Service Providers (Non-Industry Players): Distribution by Types of Service Offered
  • Table 15.11 Single cell Sequencing Service Providers (Non-Industry Players): Distribution by Type of Library Preparation System Used
  • Table 15.12 Single cell Sequencing Service Providers (Non-Industry Players): Distribution by Type of Sequencing System Used
  • Table 15.13 Single cell Sequencing Workflow Instruments: Distribution by Target Nucleic Acid
  • Table 15.14 Single cell Sequencing Workflow Instruments: Distribution by Type of Application
  • Table 15.15 Single cell Sequencing Workflow Instruments: Distribution by Throughput
  • Table 15.16 Single cell Sequencing Workflow Instrument Providers: Distribution by Year of Establishment
  • Table 15.17 Single cell Sequencing Workflow Instrument Providers: Distribution by Company Size
  • Table 15.18 Single cell Sequencing Workflow Instrument Providers: Distribution by Location of Headquarters
  • Table 15.19 Single cell Sequencing Instruments: Distribution by Type of Application
  • Table 15.20 Single cell Sequencing Instruments: Distribution by Maximum Output
  • Table 15.21 Single cell Sequencing Instruments: Distribution by Maximum Read Length
  • Table 15.22 Single cell Sequencing Instruments: Distribution by System Efficiency
  • Table 15.23 Single cell Sequencing Instruments: Distribution by Sequencing Chemistry
  • Table 15.24 Single cell Sequencing Instrument Providers: Distribution by Year of Establishment
  • Table 15.25 Single cell Sequencing Instrument Providers: Distribution by Company Size
  • Table 15.26 Single cell Sequencing Instrument Providers: Distribution by Location of Headquarters
  • Table 15.27 10x Genomics: Annual Revenues, Since 2017 (USD Million)
  • Table 15.28 Fluidigm: Annual Revenues, Since 2015 (USD Million)
  • Table 15.29 Illumina: Annual Revenues, Since 2013 (USD Billion)
  • Table 15.30 Patent Analysis: Distribution by Patent Type
  • Table 15.31 Patent Analysis: Cumulative Distribution by Publication Year, Since 2015
  • Table 15.32 Patent Analysis: Distribution by Geographical Location and Publication Year Since 2015
  • Table 15.33 Patent Analysis: Distribution by Patent Type and Publication Year
  • Table 15.34 Patent Analysis: Distribution by Geographical Location
  • Table 15.35 Patent Analysis: Distribution by Jurisdiction
  • Table 15.36 Patent Analysis: Cumulative Year-wise Distribution by Type of Applicant Since 2015
  • Table 15.37 Leading Players: Distribution by Number of Patents
  • Table 15.38 Patent Analysis: Distribution of Patents by Geographical Region and Patent Type
  • Table 15.39 Single cell Sequencing: Age of Patents
  • Table 15.40 Academic Grant Analysis: Cumulative Year-wise Trend, Since 2016
  • Table 15.41 Academic Grant Analysis: Cumulative Year-Wise Distribution by Grant Amount (USD Million)
  • Table 15.42 Academic Grant Analysis: Distribution by Activity Codes
  • Table 15.43 Academic Grant Analysis: Distribution by Support Period
  • Table 15.44 Academic Grant Analysis: Distribution by Funding Mechanism
  • Table 15.45 Academic Grant Analysis: Distribution by Type of Recipient Organization
  • Table 15.46 Popular Recipient Organizations: Distribution by Number of Grants
  • Table 15.47 Popular Recipient Organizations: Distribution by Amount Awarded (USD Million)
  • Table 15.48 Prominent Program Officers: Distribution by Number of Grants
  • Table 15.49 Recent Partnerships: Distribution by Year of Partnership
  • Table 15.50 Recent Partnerships: Distribution by Type of Agreement
  • Table 15.51 Recent Partnerships: Distribution by Focus Area of Partnership
  • Table 15.52 Recent Partnerships: Regional Distribution
  • Table 15.53 Recent Investments: Distribution by Year of Funding
  • Table 15.54 Recent Investments: Distribution by Type of Funding
  • Table 15.55 Recent Investments: Distribution by Amount Invested (USD Million)
  • Table 15.56 Most Active Players: Distribution by Amount Invested
  • Table 15.57 Most Active Investors: Distribution by Number of Funding Instances
  • Table 15.58 Recent Product Launches: Distribution by Year of Product Launch
  • Table 15.59 Recent Product Launches: Distribution by Type of Product
  • Table 15.60 Recent Product Launches: Distribution by Focus Area
  • Table 15.61 Most Active Players: Distribution by Number of Product Launches
  • Table 15.62 Overall Single cell Sequencing Services and Technologies Market Opportunity, Conservative, Base and Optimistic Scenario, Till 2030 (USD Million)
  • Table 15.63 Single cell Sequencing Services and Technologies Market Opportunity Across Key Market Segments (USD Million)
  • Table 15.64 Single cell Sequencing Services and Technologies Market Opportunity: Distribution by Type of System (USD Million)
  • Table 15.65 Single cell Sequencing Services and Technologies Market Opportunity: Distribution by End-User (USD Million)
  • Table 15.66 Single cell Sequencing Services and Technologies Market Opportunity: Distribution by Area of Application (USD Million)
  • Table 15.67 Single cell Sequencing Services and Technologies Market Opportunity: Geographical Distribution (USD Million)
  • Table 15.68 Single cell Sequencing Services and Technologies Market Opportunity in North America, Conservative, Base and Optimistic Scenario, Till 2030 (USD Million)
  • Table 15.69 Single cell Sequencing services and Technologies Market Opportunity in North America: Share of Service Providers, Till 2030 (USD Million)
  • Table 15.70 Single cell Sequencing services and Technologies Market Opportunity in North America: Share of Technology Providers, Till 2030 (USD Million)
  • Table 15.71 Single cell Sequencing services and Technologies Market Opportunity in North America: Share of Academic and Research Institutions, Till 2030 (USD Million)
  • Table 15.72 Single cell Sequencing services and Technologies Market Opportunity in North America: Share of Pharmaceutical Companies, Till 2030 (USD Million)
  • Table 15.73 Single cell Sequencing services and Technologies Market Opportunity in North America: Share of Other End-Users, Till 2030 (USD Million)
  • Table 15.74 Single cell Sequencing services and Technologies Market Opportunity in North America: Share of Diagnostics, Till 2030 (USD Million)
  • Table 15.75 Single cell Sequencing services and Technologies Market Opportunity in North America: Share of Drug Discovery, Till 2030 (USD Million)
  • Table 15.76 Single cell Sequencing services and Technologies Market Opportunity in North America: Share of Precision Medicine, Till 2030 (USD Million)
  • Table 15.77 Single cell Sequencing services and Technologies Market Opportunity in North America: Share of Other Applications, Till 2030 (USD Million)
  • Table 15.78 Single cell Sequencing Services and Technologies Market Opportunity in Europe, Conservative, Base and Optimistic Scenario, Till 2030 (USD Million)
  • Table 15.79 Single cell Sequencing services and Technologies Market Opportunity in Europe: Share of Service Providers, Till 2030 (USD Million)
  • Table 15.80 Single cell Sequencing services and Technologies Market Opportunity in Europe: Share of Technology Providers, Till 2030 (USD Million)
  • Table 15.81 Single cell Sequencing services and Technologies Market Opportunity in Europe: Share of Academic and Research Institutions, Till 2030 (USD Million)
  • Table 15.82 Single cell Sequencing services and Technologies Market Opportunity in Europe: Share of Pharmaceutical Companies, Till 2030 (USD Million)
  • Table 15.83 Single cell Sequencing services and Technologies Market Opportunity in Europe: Share of Other End-Users, Till 2030 (USD Million)
  • Table 15.84 Single cell Sequencing services and Technologies Market Opportunity in Europe: Share of Diagnostics, Till 2030 (USD Million)
  • Table 15.85 Single cell Sequencing services and Technologies Market Opportunity in Europe: Share of Drug Discovery, Till 2030 (USD Million)
  • Table 15.86 Single cell Sequencing services and Technologies Market Opportunity in Europe: Share of Precision Medicine, Till 2030 (USD Million)
  • Table 15.87 Single cell Sequencing services and Technologies Market Opportunity in Europe: Share of Other Applications, Till 2030 (USD Million)
  • Table 15.88 Single cell Sequencing Services and Technologies Market Opportunity in Asia-Pacific, Conservative, Base and Optimistic Scenario, Till 2030 (USD Million)
  • Table 15.89 Single cell Sequencing services and Technologies Market Opportunity in Asia-Pacific: Share of Service Providers, Till 2030 (USD Million)
  • Table 15.90 Single cell Sequencing services and Technologies Market Opportunity in Asia-Pacific: Share of Technology Providers, Till 2030 (USD Million)
  • Table 15.91 Single cell Sequencing services and Technologies Market Opportunity in Asia-Pacific: Share of Academic and Research Institutions, Till 2030 (USD Million)
  • Table 15.92 Single cell Sequencing services and Technologies Market Opportunity in Asia-Pacific: Share of Pharmaceutical Companies, Till 2030 (USD Million)
  • Table 15.93 Single cell Sequencing services and Technologies Market Opportunity in Asia-Pacific: Share of Other End-Users, Till 2030 (USD Million)
  • Table 15.94 Single cell Sequencing services and Technologies Market Opportunity in Asia-Pacific: Share of Diagnostics, Till 2030 (USD Million)
  • Table 15.95 Single cell Sequencing services and Technologies Market Opportunity in Asia-Pacific: Share of Drug Discovery, Till 2030 (USD Million)
  • Table 15.96 Single cell Sequencing services and Technologies Market Opportunity in Asia-Pacific: Share of Precision Medicine, Till 2030 (USD Million)
  • Table 15.97 Single cell Sequencing services and Technologies Market Opportunity in Asia-Pacific: Share of Other Applications, Till 2030 (USD Million)
  • Table 15.98 Single cell Sequencing Services and Technologies Market Opportunity in Rest of the World, Conservative, Base and Optimistic Scenario, Till 2030 (USD Million)
  • Table 15.99 Single cell Sequencing services and Technologies Market Opportunity in Rest of the World: Share of Service Providers, Till 2030 (USD Million)
  • Table 15.100 Single cell Sequencing services and Technologies Market Opportunity in Rest of the World: Share of Technology Providers, Till 2030 (USD Million)
  • Table 15.101 Single cell Sequencing services and Technologies Market Opportunity in Rest of the World: Share of Academic and Research Institutions, Till 2030 (USD Million)
  • Table 15.102 Single cell Sequencing services and Technologies Market Opportunity in Rest of the World: Share of Pharmaceutical Companies, Till 2030 (USD Million)
  • Table 15.103 Single cell Sequencing services and Technologies Market Opportunity in Rest of the World: Share of Other End-Users, Till 2030 (USD Million)
  • Table 15.104 Single cell Sequencing services and Technologies Market Opportunity in Rest of the World: Share of Diagnostics, Till 2030 (USD Million)
  • Table 15.105 Single cell Sequencing services and Technologies Market Opportunity in Rest of the World: Share of Drug Discovery, Till 2030 (USD Million)
  • Table 15.106 Single cell Sequencing services and Technologies Market Opportunity in Rest of the World: Share of Precision Medicine, Till 2030 (USD Million)
  • Table 15.107 Single cell Sequencing services and Technologies Market Opportunity in Rest of the World: Share of Other Applications, Till 2030 (USD Million)

List of Figures

  • Figure 3.1 Process of Single cell Sequencing
  • Figure 3.2 Bulk RNA Sequencing versus scRNA Sequencing
  • Figure 3.3 Applications of Single cell Sequencing
  • Figure 3.4 Challenges Associated with Single cell Sequencing
  • Figure 4.1 Single cell Sequencing Service Providers (Industry Players): Distribution by Year of Establishment
  • Figure 4.2 Single cell Sequencing Service Providers (Industry Players): Distribution by Company Size
  • Figure 4.3 Single cell Sequencing Service Providers (Industry Players): Distribution by Location of Headquarters
  • Figure 4.4 Single cell Sequencing Service Providers (Industry Players): Distribution by Sequencing Method Used
  • Figure 4.5 Single cell Sequencing Service Providers (Industry Players): Distribution by Type of Service Offered
  • Figure 4.6 Single cell Sequencing Service Providers (Industry Players): Distribution by Type of Library Preparation System Used
  • Figure 4.7 Single cell Sequencing Service Providers (Industry Players): Distribution by Type of Sequencing System Used
  • Figure 4.8 Single cell Sequencing Service Providers (Non-Industry Players): Distribution by Location of Organization
  • Figure 4.9 Single cell Sequencing Service Providers (Non-Industry Players): Distribution by Sequencing Method Used
  • Figure 4.10 Single cell Sequencing Service Providers (Non-Industry Players): Distribution by Type of Service Offered
  • Figure 4.11 Single cell Sequencing Service Providers (Non-Industry Players): Distribution by Type of Library Preparation System Used
  • Figure 4.12 Single cell Sequencing Service Providers (Non-Industry Players): Distribution by Type of Sequencing System Used
  • Figure 5.1 Single cell Sequencing Workflow Instruments: Distribution by Targeted Nucleic Acid
  • Figure 5.2 Single cell Sequencing Workflow Instruments: Distribution by Type of Application
  • Figure 5.3 Single cell Sequencing Workflow Instruments: Distribution by Throughput
  • Figure 5.4 Single cell Sequencing Workflow Instrument Providers: Distribution by Year of Establishment
  • Figure 5.5 Single cell Sequencing Workflow Instrument Providers: Distribution by Company Size
  • Figure 5.6 Single cell Sequencing Workflow Instrument Providers: Distribution by Location of Headquarters
  • Figure 5.7 Single cell Sequencing Instruments: Distribution by Type of Application
  • Figure 5.8 Single cell Sequencing Instruments: Distribution by Maximum Output
  • Figure 5.9 Single cell Sequencing Instruments: Distribution by Maximum Read Length
  • Figure 5.10 Single cell Sequencing Instruments: Distribution by System Efficiency
  • Figure 5.11 Single cell Sequencing Instruments: Distribution by Sequencing Chemistry
  • Figure 5.12 Single cell Sequencing Instrument Providers: Distribution by Year of Establishment
  • Figure 5.13 Single cell Sequencing Instrument Providers: Distribution by Company Size
  • Figure 5.14 Single cell Sequencing Instrument Providers: Distribution by Location of Headquarters
  • Figure 6.1 Platform Competitiveness Analysis: Single cell Workflow Instruments (Peer Group I)
  • Figure 6.2 Platform Competitiveness Analysis: Single cell Workflow Instruments (Peer Group II)
  • Figure 6.3 Platform Competitiveness Analysis: Single cell Sequencing Instruments (Peer Group I)
  • Figure 6.4 Platform Competitiveness Analysis: Single cell Sequencing Instruments (Peer Group II)
  • Figure 8.1 10x Genomics: Annual Revenues, Since 2017 (USD Million)
  • Figure 8.2 Fluidigm: Annual Revenues, Since 2015 (USD Million)
  • Figure 8.3 Illumina: Annual Revenues, Since 2013 (USD Billion)
  • Figure 8.4 Illumina: Sequencing Systems Portfolio
  • Figure 8.5 Oxford Nanopore Technologies: Sequencing Systems Portfolio
  • Figure 9.1 Patent Analysis: Distribution by Patent Type
  • Figure 9.2 Patent Analysis: Cumulative Distribution by Publication Year, Since 2015
  • Figure 9.3 Patent Analysis: Distribution by Geographical Location and Publication Year Since 2015
  • Figure 9.4 Patent Analysis: Distribution by Patent Type and Publication Year
  • Figure 9.5 Patent Analysis: Distribution by Geographical Location
  • Figure 9.6 Patent Analysis: Distribution by Jurisdiction
  • Figure 9.7 Patent Analysis: Distribution by CPC Symbols
  • Figure 9.8 Patent Analysis: Emerging Focus Areas
  • Figure 9.9 Patent Analysis: Cumulative Year-wise Distribution by Type of Applicant Since 2015
  • Figure 9.10 Leading Players: Distribution by Number of Patents
  • Figure 9.11 Patent Analysis (Leading Players): Benchmarking by Patent Characteristics (CPC Classifications)
  • Figure 9.12 Patent Analysis: Benchmarking by International Patents
  • Figure 9.13 Patent Analysis: Distribution of Patents by Geographical Region and Patent Type
  • Figure 9.14 Single cell Sequencing: Age of Patents
  • Figure 9.15 Patent Analysis: Valuation Analysis
  • Figure 10.1 Academic Grant Analysis: Cumulative Year-wise Trend, Since 2016
  • Figure 10.2 Academic Grant Analysis: Cumulative Year-Wise Distribution by Grant Amount (USD Million)
  • Figure 10.3 Academic Grant Analysis: Distribution by Focus Area
  • Figure 10.4 Academic Grant Analysis: Distribution by Activity Code
  • Figure 10.5 Academic Grant Analysis: Distribution by Support Period
  • Figure 10.6 Academic Grant Analysis: Distribution by Funding Mechanism
  • Figure 10.7 Academic Grant Analysis: Distribution of Funding Institute Center by Support Year and Number of Grants
  • Figure 10.8 Academic Grant Analysis: Distribution by Type of Recipient Organization
  • Figure 10.9 Popular Recipient Organizations: Distribution across States in the US
  • Figure 10.10 Popular Recipient Organizations: Distribution by Number of Grants
  • Figure 10.11 Popular Recipient Organizations: Distribution by Amount Awarded (USD Million)
  • Figure 10.12 Prominent Program Officers: Distribution by Number of Grants
  • Figure 11.1 Recent Partnerships: Distribution by Year of Partnership
  • Figure 11.2 Recent Partnerships: Distribution by Type of Agreement
  • Figure 11.3 Recent Partnerships: Distribution by Focus Area of Partnership
  • Figure 11.4 Recent Partnerships: Regional Distribution
  • Figure 11.5 Recent Investments: Distribution by Year of Funding
  • Figure 11.6 Recent Investments: Distribution by Type of Funding
  • Figure 11.7 Recent Investments: Distribution by Amount Invested (USD Million)
  • Figure 11.8 Most Active Players: Distribution by Amount Invested
  • Figure 11.9 Most Active Investors: Distribution by Number of Funding Instances
  • Figure 11.10 Recent Product Launches: Distribution by Year of Product Launch
  • Figure 11.11 Recent Product Launches: Distribution by Type of Product
  • Figure 11.12 Recent Product Launches: Distribution by Focus Area
  • Figure 11.13 Most Active Players: Distribution by Number of Product Launches
  • Figure 12.1 Overall Single cell Sequencing Services and Technologies Market Opportunity, Till 2030 (USD Million)
  • Figure 12.2 Single cell Sequencing Services and Technologies Market Opportunity Across Key Market Segments (USD Million)
  • Figure 12.3 Single cell Sequencing Services and Technologies Market Opportunity: Distribution by Type of System (USD Million)
  • Figure 12.4 Single cell Sequencing Services and Technologies Market Opportunity: Distribution by End-User (USD Million)
  • Figure 12.5 Single cell Sequencing Services and Technologies Market Opportunity: Distribution by Area of Application (USD Million)
  • Figure 12.6 Single cell Sequencing Services and Technologies Market Opportunity: Geographical Distribution (USD Million)
  • Figure 12.7 Single cell Sequencing Services and Technologies Market Opportunity in North America, Till 2030 (USD Million)
  • Figure 12.8 Single cell Sequencing Services and Technologies Market Opportunity in North America: Share of Service Providers, Till 2030 (USD Million)
  • Figure 12.9 Single cell Sequencing Services and Technologies Market Opportunity in North America: Share of Technology Providers, Till 2030 (USD Million)
  • Figure 12.10 Single cell Sequencing Services and Technologies Market Opportunity in North America: Share of Academic and Research Institutions, Till 2030 (USD Million)
  • Figure 12.11 Single cell Sequencing Services and Technologies Market Opportunity in North America: Share of Pharmaceutical Companies, Till 2030 (USD Million)
  • Figure 12.12 Single cell Sequencing Services and Technologies Market Opportunity in North America: Share of Other End-Users, Till 2030 (USD Million)
  • Figure 12.13 Single cell Sequencing Services and Technologies Market Opportunity in North America: Share of Diagnostics, Till 2030 (USD Million)
  • Figure 12.14 Single cell Sequencing Services and Technologies Market Opportunity in North America: Share of Drug Discovery, Till 2030 (USD Million)
  • Figure 12.15 Single cell Sequencing Services and Technologies Market Opportunity in North America: Share of Precision Medicine, Till 2030 (USD Million)
  • Figure 12.16 Single cell Sequencing Services and Technologies Market Opportunity in North America: Share of Other Applications, Till 2030 (USD Million)
  • Figure 12.17 Single cell Sequencing Services and Technologies Market Opportunity in Europe, Till 2030 (USD Million)
  • Figure 12.18 Single cell Sequencing Services and Technologies Market Opportunity in Europe: Share of Service Providers, Till 2030 (USD Million)
  • Figure 12.19 Single cell Sequencing Services and Technologies Market Opportunity in Europe: Share of Technology Providers, Till 2030 (USD Million)
  • Figure 12.20 Single cell Sequencing Services and Technologies Market Opportunity in Europe: Share of Academic and Research Institutions, Till 2030 (USD Million)
  • Figure 12.21 Single cell Sequencing Services and Technologies Market Opportunity in Europe: Share of Pharmaceutical Companies, Till 2030 (USD Million)
  • Figure 12.22 Single cell Sequencing Services and Technologies Market Opportunity in Europe: Share of Other End-Users, Till 2030 (USD Million)
  • Figure 12.23 Single cell Sequencing Services and Technologies Market Opportunity in Europe: Share of Diagnostics, Till 2030 (USD Million)
  • Figure 12.24 Single cell Sequencing Services and Technologies Market Opportunity in Europe: Share of Drug Discovery, Till 2030 (USD Million)
  • Figure 12.25 Single cell Sequencing Services and Technologies Market Opportunity in Europe: Share of Precision Medicine, Till 2030 (USD Million)
  • Figure 12.26 Single cell Sequencing Services and Technologies Market Opportunity in Europe: Share of Other Applications, Till 2030 (USD Million)
  • Figure 12.27 Single cell Sequencing Services and Technologies Market Opportunity in Asia-Pacific, Till 2030 (USD Million)
  • Figure 12.28 Single cell Sequencing services and Technologies Market Opportunity in Asia-Pacific: Share of Service Providers, Till 2030 (USD Million)
  • Figure 12.29 Single cell Sequencing services and Technologies Market Opportunity in Asia-Pacific: Share of Technology Providers, Till 2030 (USD Million)
  • Figure 12.30 Single cell Sequencing services and Technologies Market Opportunity in Asia-Pacific: Share of Academic and Research Institutions, Till 2030 (USD Million)
  • Figure 12.31 Single cell Sequencing Services and Technologies Market Opportunity in Asia-Pacific: Share of Pharmaceutical Companies, Till 2030 (USD Million)
  • Figure 12.32 Single cell Sequencing Services and Technologies Market Opportunity in Asia-Pacific: Share of Other End-Users, Till 2030 (USD Million)
  • Figure 12.33 Single cell Sequencing Services and Technologies Market Opportunity in Asia-Pacific: Share of Diagnostics, Till 2030 (USD Million)
  • Figure 12.34 Single cell Sequencing Services and Technologies Market Opportunity in Asia-Pacific: Share of Drug Discovery, Till 2030 (USD Million)
  • Figure 12.35 Single cell Sequencing Services and Technologies Market Opportunity in Asia-Pacific: Share of Precision Medicine, Till 2030 (USD Million)
  • Figure 12.36 Single cell Sequencing Services and Technologies Market Opportunity in Asia-Pacific: Share of Other Applications, Till 2030 (USD Million)
  • Figure 12.37 Single cell Sequencing Services and Technologies Market Opportunity in Rest of the World, Till 2030 (USD Million)
  • Figure 12.38 Single cell Sequencing Services and Technologies Market Opportunity in Rest of the World: Share of Service Providers, Till 2030 (USD Million)
  • Figure 12.39 Single cell Sequencing Services and Technologies Market Opportunity in Rest of the World: Share of Technology Providers, Till 2030 (USD Million)
  • Figure 12.40 Single cell Sequencing Services and Technologies Market Opportunity in Rest of the World: Share of Academic and Research Institutions, Till 2030 (USD Million)
  • Figure 12.41 Single cell Sequencing Services and Technologies Market Opportunity in Rest of the World: Share of Pharmaceutical Companies, Till 2030 (USD Million)
  • Figure 12.42 Single cell Sequencing Services and Technologies Market Opportunity in Rest of the World: Share of Other End-Users, Till 2030 (USD Million)
  • Figure 12.43 Single cell Sequencing Services and Technologies Market Opportunity in Rest of the World: Share of Diagnostics, Till 2030 (USD Million)
  • Figure 12.44 Single cell Sequencing Services and Technologies Market Opportunity in Rest of the World: Share of Drug Discovery, Till 2030 (USD Million)
  • Figure 12.45 Single cell Sequencing Services and Technologies Market Opportunity in Rest of the World: Share of Precision Medicine, Till 2030 (USD Million)
  • Figure 12.46 Single cell Sequencing Services and Technologies Market Opportunity in Rest of the World: Share of Other Applications, Till 2030 (USD Million)